Last Updated On 11/21/2024 10:05:55 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Novartis |
| Recipient: You |
| Company: Kite/Gilead |
| Recipient: You |
| Company: Janssen Scientific Affairs |
| Recipient: You |
| Company: ADC Therapeutics |
| Recipient: You |
| Company: Bristol-Myers Squibb/Celgene/Juno |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: MorphoSys/Incyte |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Chugai Pharma |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: Nurix |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Allogene Therapeutics |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Janssen |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Kite/Gilead |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: MorphoSys/Incyte |
| Recipient: You |
| Company: ADC Therapeutics |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Allogene Therapeutics |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|